- Contractors
- Vaxine Pty Ltd
Vaxine Pty Ltd
Federal contractor · Research and Development in Biotechnology (except Nanobiotechnology)
Vaxine Pty has 2 federal contracts of $100,000 or more active since October 2023, with $12.5M obligated, from 1 agency. None is running now.
- Contracts
- 2 since FY2024$12,522,681 obligated, contracts of $100,000 or more
- Running now
- None
- Biggest customer
- National Institutes of Health$12.5M on 2 contracts
- Main industry
- Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714
- UEI
- Z9AUC2SNX5A4Unique entity ID in SAM.gov
- Source
- USAspending.govUpdated Nov 17, 2026, 7:02 PM UTC
Running contracts
No contract of $100,000 or more is running now.
Who they work for
| Agency | Amount | Share |
|---|---|---|
| National Institutes of Health2 contracts | $12,522,681 |
What they sell
| Industry | Amount | Share |
|---|---|---|
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 · 2 contracts | $12,522,681 |
Source: USAspending.gov, prime contracts of $100,000 or more with an action since October 1, 2023. Department of Defense contracts appear there about 90 days after award. Other contracts ending soon at National Institutes of Health: see the list.
Get new notices like Vaxine Pty's work
New contract opportunities under NAICS 541714, research and development in biotechnology (except nanobiotechnology), the morning they appear. Free while in beta.
Free. We use your email only for these alerts and never share it. Privacy